Zalicus
Julie H. McHugh (Independent Director)
Summary
History
Zalicus Inc. was founded in 2001 by Dr. Mark H.N. Corrigan to develop novel treatments for pain and other diseases. In 2008, the company announced a merger with CombinatoRx, a clinical-stage biopharmaceutical company focused on the development of novel, synergistic combination therapies. The merger added to Zalicus' pipeline of pain management candidates, which included Z160, Z944 and SYN-115, and expanded its therapeutic areas to include inflammation and immunology. Zalicus has successfully developed a pipeline of clinical-stage product candidates that have the potential to address significant unmet medical needs.
Mission
Vision
Key Team
Julie H. McHugh (Independent Director)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Julie H. McHugh (Independent Director)